After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Ginkgo Bioworks Holdings Inc is listed on the NYSE as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Ginkgo Bioworks Holdings Inc is $409.14M. A total of 1.03 million shares were traded on the day, compared to an average of 1.44M shares.
In the most recent transaction, Che Austin bought 99 shares of DNA for 6.75 per share on May 23 ’25. In a previous transaction on May 21 ’25, Coen Steven P. sold 346 shares at 7.58 per share. DNA shares that the insider owns now total 9,216.
Among the insiders who sold shares, Dmytruk Mark E. disposed of 706 shares on May 21 ’25 at a per-share price of $7.58. This resulted in the insider holding 46,226 shares of DNA after the transaction. In another insider transaction, Che Austin bought 99 shares at $7.15 per share on May 22 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, DNA has a high of $28.80 and a low of $5.00.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DNA’s latest balance sheet shows that the firm has $1.55B in Cash & Short Term Investments as of fiscal 2021. There were $23.03M in debt and $134.76M in liabilities at the time. Its Book Value Per Share was $12.52, while its Total Shareholder’s Equity was $1.57B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DNA is Buy with a score of 2.17.
